CSPC PHARMACEUT.GR. ADR4 (CVGU) — Cash Flow Reinvestment Rate
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Cash Flow Reinvestment Rate of 0.74x as of December 2025, reinvesting €4.33 Billion (capex €2.28 Billion plus investments €-2.05 Billion) from operating cash flow of €5.83 Billion. See CSPC PHARMACEUT.GR. ADR4 (CVGU) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CSPC PHARMACEUT.GR. ADR4 Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. For the full cash flow conversion analysis, see CVGU operating cash flow.
Annual Cash Flow Reinvestment Rate for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Year-by-year capital reinvestment analysis for CSPC PHARMACEUT.GR. ADR4. See CSPC PHARMACEUT.GR. ADR4 leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €4.33 Billion | €5.83 Billion | €2.28 Billion | ▼ -18.3% |
| 2024 | 0.91x | €4.12 Billion | €4.53 Billion | €2.68 Billion | ▼ -9.1% |
| 2023 | 1.00x | €4.18 Billion | €4.18 Billion | €1.89 Billion | ▲ +15.8% |
| 2022 | 0.86x | €6.59 Billion | €7.63 Billion | €2.72 Billion | ▲ +114.8% |
| 2021 | 0.40x | €1.86 Billion | €4.64 Billion | €1.76 Billion | — |